2009 Update in prevention, evaluation, and outpatient treatment of influenza

Current Medical Research and Opinion

Volumn 25, Issue 4, 2009, Pages 817-828

  Williams, James M ^a,b  

^a Methodist Specialty and Transplant Hospital   (United States)

^b NONE   (United States)

Author keywords

Antivirals; Influenza; Oseltamivir; Vaccination; Zanamivir

Indexed keywords

AMANTADINE; FLULAVAL; INFLUENZA VACCINE; OSELTAMIVIR; RIMANTADINE; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG; ZANAMIVIR;

BRONCHOSPASM; COUGHING; DIARRHEA; DISEASE TRANSMISSION; DRUG DOSE REDUCTION; DRUG FATALITY; DYSPNEA; EVALUATION; FEVER; FLU LIKE SYNDROME; FOOD AND DRUG ADMINISTRATION; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; LABORATORY TEST; NAUSEA; NONHUMAN; NOSE CONGESTION; OUTPATIENT CARE; PALLIATIVE THERAPY; PRIMARY MEDICAL CARE; REVIEW; RHINORRHEA; SORE THROAT; UNITED STATES; VOMITING;

ANTIVIRAL AGENTS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); HUMANS; INCIDENCE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; OUTPATIENTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VACCINATION; VACCINES, INACTIVATED;

EID: 67649306837     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990802708244     Document Type: Review

References (90)

1. Fiore A, Shay DK, Broder K, et al. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Morb Mortal Wkly Rep 2008;57:1-60
2. Thompson WW, Comanor L, Shay DK. Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis 2006;194(Suppl 2):S82-S91 (Pubitemid 44630951)
3. Homeland Security Council. National Strategy for Pandemic Influenza: Implementation Plan. May 2006. Available at: http://www.whitehouse.gov/homeland/ nspi-implementation.pdf [Last accessed October 10, 2008]
4. World Health Organization. Epidemic and pandemic alert and response (EPR). Influenza. Available at: http://www.who.int/csr/disease/influenza/en/ [Last accessed October 10, 2008]
5. Jefferson T, Foxlee R, Del Mar C, et al. Interventions for the interruption or reduction of the spread of respiratory viruses. Cochrane Database Syst Rev 2007;4:CD006207 (Pubitemid 351805265)
6. Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998;158:1769-1776 (Pubitemid 28421420)
7. Bridges CB, Thompson WW, Meltzer MI, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 2000;284:1655-1663 (Pubitemid 30740388)
8. Hak E, Buskens E, van Essen GA, et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med 2005;165:274-280 (Pubitemid 40216278)
9. US Centers for Disease Control and Prevention. Interim within-season estimate of effectiveness of trivalent influenza vaccine - Marshfield, Wisconsin, 2007-2008 influenza season. MMWR Morb Mortal Wkly Rep 2008;57:393-398
10. US Centers for Disease Control and Prevention. 2008-09 Influenza prevention & control recommendations. Influenza vaccination coverage levels. Available at: http://www.cdc.gov/flu/professionals/vaccination/coveragelevels. htm [Last accessed October 6, 2008]
11. Nowalk MP, Zimmerman RK, Shen S, et al. Barriers to pneumococcal and influenza vaccination in older community-dwelling adults (2000-2001). J Am Geriatr Soc 2004;52:25-30
12. Zimmerman RK, Nowalk MP, Raymund M, et al. Tailored interventions to increase influenza vaccination in neighborhood health centers serving the disadvantaged. Am J Public Health 2003;93:1699-1705 (Pubitemid 38477638)
13. Harris LM, Chin NP, Fiscella K, et al. Barrier to pneumococcal and influenza vaccinations in Black elderly communities: mistrust. J Natl Med Assoc 2006;98:1678-1684 (Pubitemid 44682964)
14. Paul IM, Eleoff SB, Shaffer ML, et al. Improving influenza vaccination rates for children through year-round scheduling. Ambul Pediatr 2006;6:230-234
15. Postema AS, Breiman RF; National Vaccine Advisory Committee. Adult immunization programs in nontraditional settings: quality standards and guidance for program evaluation. MMWR Recomm Rep 2000;49(RR-1):1-13
16. McKibben LJ, Stange PV, Sneller VP, et al. Advisory Committee on Immunization Practices. Use of standing orders programs to increase adult vaccination rates. MMWR Recomm Rep 2000;49:15-26
17. Smith NM, Bresee JS, Shay DK, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55:1-42
18. US Department of Health and Human Services. HHS pandemic influenza plan. Supplement 4. Infection control. Available at: http://www.hhs.gov/pandemicflu/ plan/sup4.html modes [Last accessed October 1, 2008]
19. Brankston G, Gitterman L, Hirji Z, et al. Transmission of influenza A in human beings. Lancet Infect Dis 2007;7:257-265 (Pubitemid 46414066)
20. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in health care settings. Clin Infect Dis. 2003;37:1094-1101 (Pubitemid 37323665)
21. Moser MR, Bender TR, Margolis HS, et al. An outbreak of influenza aboard a commercial airliner. Am J Epidemiol 1979;110:1-6 (Pubitemid 10207328)
22. Blumenfeld HL, Kilbourne ED, Louria DB, et al. Studies on influenza in the pandemic of 1957-1958. I. An epidemiologic, clinical and serologic investigation of an intrahospital epidemic, with a note on vaccination efficacy. J Clin Invest 1959;38(1 Part 2):199-212
23. Boone SA, Gerba CP. The occurrence of influenza A virus on household and day care center fomites. J Infect 2005;51:103-109 (Pubitemid 40984343)
24. Cox NJ, Subbarao K. Influenza. Lancet 1999;354:1277-1282
25. Hayden FG, Fritz R, Lobo MC, et al. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 1998;101:643-649 (Pubitemid 28084248)
26. Leekha S, Zitterkopf NL, Espy MJ, et al. Duration of influenza A virus shedding in hospitalized patients and implications for infection control. Infect Control Hosp Epidemiol 2007;28:1071-1076 (Pubitemid 47345268)
27. Friedman MJ, Attia MW. Clinical predictors of influenza in children. Arch Pediatr Adolesc Med 2004;158:391-394 (Pubitemid 38451569)
28. Ohmit SE, Monto AS. Symptomatic predictors of influenza virus positivity in children during the influenza season. Clin Infect Dis 2006;43:564-568 (Pubitemid 44267114)
29. Boivin G, Hardy I, Tellier G, et al. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis 2000;31:1166-1169 (Pubitemid 32295445)
30. Monto AS, Gravenstein S, Elliott M, et al. Clinical signs and symptoms predicting influenza infection. Arch Intern Med 2000;160:3243-3247 (Pubitemid 30842428)
31. Stein J, Louie J, Flanders S, et al. Performance characteristics of clinical diagnosis, a clinical decision rule, and a rapid influenza test in the detection of influenza infection in a community sample of adults. Ann Emerg Med 2005;46:412-419 (Pubitemid 41554177)
32. Eskin B, Levy R. Evidence-based emergency medicine/rational clinical examination abstract. Does this patient have influenza? Ann Emerg Med 2007;49:103-105
33. Dolin R. Influenza. In: Kasper DL, Fauci AS, Longo DL, et al., eds. Harrison's Principles of Internal Medicine, 16th edn. New York: McGraw-Hill, 2005:1066-1070
34. US Department of Health and Human Services. Is it a cold or the flu? Available at: http://www3.niaid.nih.gov/topics/Flu/PDF/sick.pdf [Last accessed October 1, 2008]
35. Ashfraf J, Bellantonio S, Natanasabapathy S. Treatment and prevention of influenza. In: Gantz NM, Brown RB, Berk SL, et al., eds. Manual of Clinical Problems in Infectious Diseases, 5th edn. New York: Lippincott Williams & Wilkins, 2006:481-485
36. Peltola V, Ziegler T, Ruuskanen O. Influenza A and B virus infections in children. Clin Infect Dis 2003;36:299-305
37. Montalto NJ. An office-based approach to influenza: clinical diagnosis and laboratory testing. Am Fam Physician 2003;67:111-118 (Pubitemid 36227392)
38. US Food and Drug Administration. Performance and cautions in using rapid influenza virus diagnostic tests. Available at: http://www.fda.gov/cdrh/oivd/ labsafetytips.html#tip2 [Last accessed October 1, 2008]
39. Rodriguez WJ, Schwartz RH, Thorne MM. Evaluation of diagnostic tests for influenza in a pediatric practice. Pediatr Infect Dis J 2002;21:193-196 (Pubitemid 34214134)
40. US Centers for Disease Control and Prevention. Rapid diagnostic testing for influenza: information for healthcare professionals. December 4, 2006. Available at: http://www.cdc.gov/flu/professionals/diagnosis/rapidclin.htm [Last accessed October 1, 2008]
41. Grijalva CG, Poehling KA, Edwards KM, et al. Accuracy and interpretation of rapid influenza tests in children. Pediatrics 2007;119:e6-e11 (Pubitemid 46397799)
42. Hueston WJ, Benich JJ. A cost-benefit analysis of testing for influenza A in high-risk adults. Ann Fam Med 2004;2:33-40. Erratum in: Ann Fam Med 2004;2:179 (Pubitemid 39318017)
43. Rojo JC, Ruiz-Contreras J, Fernandez MB, et al. Influenza-related hospitalizations in children younger than three years of age. Pediatr Infect Dis J 2006;25:596-601 (Pubitemid 43995355)
44. McBean AM, Babish JD, Warren JL. The impact and cost of influenza in the elderly. Arch Intern Med 1993;153:2105-2111 (Pubitemid 23286463)
45. Glezen WP, Decker M, Perrotta DM. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. Am Rev Respir Dis 1987;136:550-555
46. Ampofo K, Gesteland PH, Bender J, et al. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics 2006;118:2409-2417 (Pubitemid 46397581)
47. Neuzil KM, Reed GW, Mitchel EF Jr, et al. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA 1999;281:901-907 (Pubitemid 29124633)
48. Foster DA, Talsma A, Furumoto-Dawson A, et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol 1992;136:296-307
49. Moss SE, Klein R, Klein BE. Cause-specific mortality in a population-based study of diabetes. Am J Public Health 1991;81:1158-1162
50. Ljungman P, Andersson J, Aschan J, et al. Influenza A in immunocompromised patients. Clin Infect Dis 1993;17:244-247 (Pubitemid 23228463)
51. Neuzil KM, Reed GW, Mitchel EF, et al. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998;148:1094-1102 (Pubitemid 28562169)
52. Kark JD, Lebiush M, Rannon L. Cigarette smoking as a risk factor for epidemic A(H1N1) influenza in young men. N Engl J Med 1982;307:1042-1046
53. Nicholson KG, Kent J, Hammersley V. Influenza A among community-dwelling elderly persons in Leicestershire during winter 1993-4; cigarette smoking as a risk factor and the efficacy of influenza vaccination. Epidemiol Infect 1999;123:103-108
54. Keren R, Zaoutis TE, Bridges CB, et al. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA 2005;294:2188-2194 (Pubitemid 41571136)
55. Stamboulian D, Bonvehi PE, Nacinovich FM, et al. Influenza. Infect Dis Clin North Am 2000;14:141-166
56. Khater F, Moorman JP. Complications of influenza. South Med J 2003;96:740-743 (Pubitemid 38281682)
57. Chen Y, Stewart P, Dales R, et al. In a retrospective study of chronic obstructive pulmonary disease inpatients, respiratory comorbidities were significantly associated with prognosis. J Clin Epidemiol 2005;58:1199-1205
58. Teichtahl H, Buckmaster N, Pertnikovs E. The incidence of respiratory tract infection in adults requiring hospitalization for asthma. Chest 1997;112:591-596 (Pubitemid 27410692)
59. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995;310:1225-1229
60. Hordvik NL, Konig P, Hamory B, et al. Effects of acute viral respiratory tract infections in patients with cystic fibrosis. Pediatr Pulmonol 1989;7:217-222
61. Nichol KL, Margolis KL, Wuorenma J, et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994;331:778-784 (Pubitemid 24284768)
62. Gurfinkel EP, de la Fuente RL, Mendiz O, et al. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation. 2002;105:2143-2147 (Pubitemid 34517156)
63. Madjid M, Miller CC, Zarubaev VV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34 892 subjects. Eur Heart J 2007;28:1205-1210 (Pubitemid 47343835)
64. Karjalainen J, Nieminen MS, Heikkila J. Influenza A1 myocarditis in conscripts. Acta Med Scand 1980;207:27-30 (Pubitemid 10157205)
65. Greaves K, Oxford JS, Price CP, et al. The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: measurement of cardiac troponins I and T in 152 patients with acute influenza infection. Arch Intern Med 2003;163:165-168 (Pubitemid 36120184)
66. Lin CH, Huang YC, Chiu CH, et al. Neurologic manifestations in children with influenza B virus infection. Pediatr Infect Dis J 2006;25:1081-1083 (Pubitemid 44657825)
67. Newland JG, Laurich VM, Rosenquist AW, et al. Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors. J Pediatr 2007;150:306-310 (Pubitemid 46328959)
68. Belay ED, Bresee JS, Holman RC, et al. Reye's syndrome in the United States from 1981 through 1997. N Engl J Med 1999;340:1377-1382
69. Tamiflu [prescribing information]. Nutley, NJ: Roche Pharmaceuticals; 2008
70. Relenza [prescribing information]. Research Triangle Park, NC: GlaxoSmithKline; 2008
71. Bright RA, Shay DK, Shu B, et al. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA. 2006;295:891-894
72. Kawai N, Ikematsu H, Iwaki N, et al. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons. Clin Infect Dis 2006;43:439-444
73. Sugaya N, Mitamura K, Yamazaki M, et al. Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis 2007;44:197-202 (Pubitemid 46079980)
74. Monto AS, McKimm-Breschkin JL, Macken C, et al. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 2006;50:2395-2402 (Pubitemid 43993177)
75. Hatakeyama S, Sugaya N, Ito M, et al. Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA 2007;297:1435-1442 (Pubitemid 46556469)
76. US Centers for Disease Control and Prevention. Influenza activity - United States and worldwide, 2007-2008 season. MMWR Morb Mortal Wkly Rep 2008;57;692-697
77. Barnett JM, Cadman A, Gor D, et al. Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies. Antimicrob Agents Chemother 2000;44:78-87 (Pubitemid 30010676)
78. Gubareva LV, Kaiser L, Matrosovich MN, et al. Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J Infect Dis 2001;183:523-531 (Pubitemid 32147507)
79. US Centers for Disease Control andPrevention. Update: Influenza activity -United States, September 28-November 29, 2008. MMWR Morb Mortal Wkly Rep 2008;57:1329-1332
80. Jefferson TO, Demicheli V, Di Pietrantonj C, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev 2006;(3):001265
81. Matheson NJ, Hamden AR, Perera R, et al. Cochrane Database Syst Rev 2007;1(CD002744)
82. Okumura A, Kubota T, Kato T, et al. Oseltamivir and delirious behavior in children with influenza. Pediatr Infect Dis J 2006;25:572 (Pubitemid 43863379)
83. US Food and Drug Administration. 2008 Safety alerts for human medical products. Available at: http://www.fda.gov/medwatch/safety/2008/safety08. htm#Tamiflu [Last accessed October 3, 2008]
84. Hayden FG, Atmar RL, Schilling M, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999;341:1336-1343 (Pubitemid 29503572)
85. Monto AS, Pichichero ME, Blanckenberg SJ, et al. Zanamivir prophylaxis an effective strategy for the prevention of influenza types A and B within households. J Infect Dis 2002;186:1582-1588 (Pubitemid 35379634)
86. Halloran ME, Hayden FG, Yang Y, et al. Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. Am J Epidemiol 2007;165:212-221 (Pubitemid 46096383)
87. Peters PH, Jr., Gravenstein S, Norwood P, et al. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc 2001;49:1025-1031 (Pubitemid 32801138)
88. Barr CE, Schulman K, Iacuzio D, et al. Effect of oseltamivir on the risk of pneumonia and use of health care services in children with clinically diagnosed influenza. Curr Med Res Opin 2007;23:523-531 (Pubitemid 46456900)
89. Smith SM, Schroeder K, Fahey T. Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev 2008;1(CD001831)
90. US Centers for Disease Control and Prevention (CDC). Infant deaths associated with cough and cold medications - two states, 2005. MMWR Morb Mortal Wkly Rep 2007;56:1-4